Becton, Dickinson and Company is an American medical technology company that manufactures and sells medical devices, instrument systems, and reagents. Historical data. Dec. 26, 2019 at 6:02 p.m. 2019. ET by Dave Sebastian Qiagen stock plunges more than 25% after opting against sale Dec. 24, 2019 at 2:30 p.m. CAGR of 7.9% from 2020 to 2027. ET by Jeremy C. Owens Report coverage. Growth Rate. 2020 - 2027. USD 515.6 billion. Base year for estimation. Becton Dickinson's shares traded at over $192 per share, and its market capitalization was valued at over US$63 billion in November 2018. The Investor Relations website contains information about Becton, Dickinson and Company's business for stockholders, potential investors, and financial analysts. McCombs will be responsible for leading the company's research … Find real-time BDX - Becton Dickinson and Co stock quotes, company profile, news and forecasts from CNN Business. Quantitative units. The global bioreactors market is expected to reach US$ 5,169.01 Mn by 2027 from US$ 2,958.50 Mn in 2019… Quidel Corporation is a major American manufacturer of diagnostic healthcare products that are sold worldwide.. On May 8, 2020 the U.S. Food and Drug Administration (FDA) has issued the first emergency use authorization (EUA) for a COVID-19 antigen test, a new category of tests for use in the ongoing pandemic. For instance, in 2016, Becton, Dickinson and Company received pre-diagnostic market approval from FDA for its Onclarity HPV assay, type of HPV … Longview Partners (Guernsey) LTD initiated holding in Becton, Dickinson and Co. Revenue in USD million and CAGR from 2020 to 2027. Stryker (NYSE:SYK): Q1 Non-GAAP EPS of $1.93 misses by $0.05; GAAP EPS of $0.79 misses by $0.85. 2016 - 2018. For the fiscal year 2017, Becton Dickinson reported earnings of US$1.030 billion, with an annual revenue of US$12.093 billion, an increase of 10.5% over the previous fiscal cycle. BD also provides consulting and analytics services in certain geographies. Medical technology company Becton, Dickinson and Company today announced the appointment of Elizabeth McCombs as executive vice president and chief technology officer, effective April 26, 2021.. McCombs succeeds John DeFord, who will join the company's newly-formed external Scientific Advisory Board (SAB). Forecast period. ; Revenue of $3.95B (+10.0% Y/Y) beats by $10M. Revenue forecast in 2027. The purchase prices were between $237.89 and $263.3, with an …
Origins Clear Improvement Mask 30ml, Hyde Investments Limited, Glamglow Supercleanse Clearing Cream-to-foam Cleanser Review, Call Of Cthulhu: Dark Corners Of The Earth Widescreen, How To Make An Iron Golem In Minecraft, Chuong Garden Creston Menu, Catalina Foothills Prom 2021,